Zoetis Launches Suvaxyn® PRRS MLV In the European Union

Zoetis today announced the launch of Suvaxyn® PRRS MLV in most European Union countries, an innovative vaccine containing a modified live European Porcine Reproductive and Respiratory Syndrome (PRRS) virus strain, grown in a unique cell line for whole herd protection against PRRS.
calendar icon 16 January 2018
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.